Movement Alert|NEBIUS Falls 3.59% in Pre-Market Trading, BNP Paribas Neutral Rating and Sector-Wide Pressure Weigh on Shares

Market Focus
Yesterday

On June 5, NEBIUS fell 3.59% in pre-market trading, trading at approximately $249.54/share, with trading volume of $4.38 million.

On the news front, BNP Paribas initiated coverage on NEBIUS with a Neutral rating and a $255 price target. The analyst team led by Stefan Slowinski noted that the stock has surged more than 210% year-to-date as a popular vehicle for investors betting on AI compute scarcity, but the sharp rally has compressed future upside potential. BNP Paribas simultaneously initiated coverage on competitor CoreWeave with an Outperform rating at a $192 target, signaling a relative preference shift. Prior to this, investment bank D.A. Davidson had also issued a warning on the stock.

Additionally, the Systems Software sector faced broad downward pressure, with Oracle down 1.48%, CrowdStrike down 1.41%, and Palo Alto Networks down 0.69%, creating a sector-wide drag that amplified NEBIUS's pullback. Insider selling activity disclosed on June 3 — including executive Marc Boroditsky selling 10,800 shares at $276.20 — may also be contributing to cautious sentiment.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10